Rapid elimination of circulating leukemia cells with a small dose of alemtuzumab in refractory aggressive NK-cell leukemia
Makoto Sasaki,
Makoto Sasaki
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author Koichi Sugimoto,
Koichi Sugimoto
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author Shimpei Kawahara,
Shimpei Kawahara
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author Hajime Yasuda,
Hajime Yasuda
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author Hiroko Suto,
Hiroko Suto
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author Kazuo Oshimi,
Kazuo Oshimi
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author
Makoto Sasaki,
Makoto Sasaki
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author Koichi Sugimoto,
Koichi Sugimoto
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author Shimpei Kawahara,
Shimpei Kawahara
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author Hajime Yasuda,
Hajime Yasuda
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author Hiroko Suto,
Hiroko Suto
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author Kazuo Oshimi,
Kazuo Oshimi
Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
Search for more papers by this author
First published: 14 March 2007
Koichi Sugimoto, MD, Division of Hematology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. Tel: +81 3 3813 3111, ext. 3386; Fax: +81 3 3813 0841;e-mail:
[email protected] No abstract is available for this article.
References
- 1
Golay J,
Manganini M,
Rambaldi A,
Introna M.
Effect of alemtuzumab on neoplastic B cells.
Haematologica
2004; 89: 1476–83.
- 2
Stanglmaier M,
Reis S,
Hallek M.
Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells.
Ann Hematol
2004; 83: 634–45.
- 3
Murdock J,
Jaffe ES,
Wilson WH,
McManus DT,
Alexander HD,
Morris TC.
Aggressive natural killer cell leukemia/lymphoma: case report, use of Telesynergy and review of the literature.
Leuk Lymphoma
2004; 45: 1269–73.
